Date of Issuance: March 05, 2025 Location: United States Product Type: Sterile Drug Products (Outsourcing Facility) Annovex Pharma, operating as a 503B outsourcing facility, faced citations related to the integrity of sterile production records
Rahman A, Tamseel S, Dutta S, Khan N, Faaiz M, Rastogi H, Nath JR, Haldar K, Chowdhury P, Ashish, Bhattacharjee S
The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension 30
A comprehensive understanding of the complex pathophysiology in WD cells may result in the identification of potential direct-acting therapeutic targets
In recent years, testosterone cypionate for women has gained attention as a therapeutic option for addressing symptoms related to low testosterone levels, such as fatigue, low